ChrysCapital-backed fund crosses 5% stake in Bliss GVS Pharma via open market buy

Creeping Acquisition Near ThresholdOwnership Changes View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.2%1-day move

₹447.50

prior close

₹450.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.2+0.7+1.8+3.2+2.0————————

Up moveDown movePending

AI summary

Clarus Trust (managed by ChrysCapital Associates) bought 1,84,652 shares (0.17%) of Bliss GVS Pharma in the open market on July 20, 2026. Its holding along with PAC ClearEdge LLC rose from 4.95% to 5.13%, crossing the 5% disclosure threshold under SEBI Takeover Regulations. The acquirer is not a promoter of the company.

Likely market impact

A non-promoter institutional investor crossed the 5% stake threshold, signalling confidence. No mandatory open offer is triggered at this level.